患有不同胸病理的MG患者的预后:多中心回顾性队列研究
Moli Fan1, Hao Zhang1, Yutong Shi1
1Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
BMC medicine
|December 16, 2025
概括
肌痛性骨髓灰质炎 (MG) 患者的胸腺瘤与胸腺切除术后临床恶化风险的增加有关. 这种关联不论是胸腺瘤的亚型或阶段,都会持续存在,突出显示胸腺瘤是关键的预后因素.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 骨髓灰质炎 (MG) 是一种影响神经肌肉结合的自身免疫性疾病.
- 在MG患者中经常观察到胸膜异常,包括胸膜瘤.
- 了解胸膜病理对MG预后的影响对于治疗策略至关重要.
研究的目的:
- 为了研究经过胸膜切除术的骨髓灰质炎 (MG) 患者的胸膜病理和临床结果之间的关联.
- 为了确定胸腺瘤的存在是否会影响术后恶化,缓解率或疾病进展.
主要方法:
- 一个多中心的回顾性研究包括1,254名接受了乳腺切除术的MG患者.
- 根据胸膜病理学,患者被分为胸膜发病和非胸膜发病组.
- 评估的结果包括术后恶化,达到最小表现状态 (MMS) 和从眼部转换为通用MG (OMG到GMG).
主要成果:
- 胸腺瘤的存在与术后临床恶化的风险增加有显著关联 (HR=1.40,p<0.001).
- 胸腺瘤也与从眼部转化为通用MG的更高转化率相关 (OR=2.37,p=0.019).
- 胸腺瘤与达到最小表现状态 (MMS) 或世卫组织病理类型/Masaoka阶段和预后之间没有发现显著的关联.
结论:
- 胸腺瘤是MG患者胸腺切除术后预后较差的一个独立风险因素.
- 胸腺瘤患者的临床恶化和疾病进展风险较高,无论具体的病理类型或阶段.
- 进一步的研究可能会探索针对MG患者的瘤的向治疗方法.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K


